222 related articles for article (PubMed ID: 27593923)
21. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
Zhai H; Fesler A; Ba Y; Wu S; Ju J
Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
[TBL] [Abstract][Full Text] [Related]
22. Stem Cells Antigen-1 Enriches for a Cancer Stem Cell-Like Subpopulation in Mouse Gastric Cancer.
Park JW; Park JM; Park DM; Kim DY; Kim HK
Stem Cells; 2016 May; 34(5):1177-87. PubMed ID: 26869189
[TBL] [Abstract][Full Text] [Related]
23. Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer.
Nakano M; Kikushige Y; Miyawaki K; Kunisaki Y; Mizuno S; Takenaka K; Tamura S; Okumura Y; Ito M; Ariyama H; Kusaba H; Nakamura M; Maeda T; Baba E; Akashi K
Oncogene; 2019 Feb; 38(6):780-793. PubMed ID: 30181548
[TBL] [Abstract][Full Text] [Related]
24. High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients.
Chen X; Sun K; Jiao S; Cai N; Zhao X; Zou H; Xie Y; Wang Z; Zhong M; Wei L
Sci Rep; 2014 Dec; 4():7481. PubMed ID: 25500546
[TBL] [Abstract][Full Text] [Related]
25. Suppression of CD51 in pancreatic stellate cells inhibits tumor growth by reducing stroma and altering tumor-stromal interaction in pancreatic cancer.
Horioka K; Ohuchida K; Sada M; Zheng B; Moriyama T; Fujita H; Manabe T; Ohtsuka T; Shimamoto M; Miyazaki T; Mizumoto K; Oda Y; Nakamura M
Int J Oncol; 2016 Apr; 48(4):1499-508. PubMed ID: 26846197
[TBL] [Abstract][Full Text] [Related]
26. Preclinical analysis of the anti-tumor and anti-metastatic effects of Raf265 on colon cancer cells and CD26(+) cancer stem cells in colorectal carcinoma.
Chow AK; Cheng NS; Lam CS; Ng L; Wong SK; Wan TM; Man JH; Cheung AH; Yau TC; Poon JT; Law WL; Pang RW
Mol Cancer; 2015 Apr; 14():80. PubMed ID: 25884645
[TBL] [Abstract][Full Text] [Related]
27. Pien Tze Huang inhibits liver metastasis by targeting TGF-β signaling in an orthotopic model of colorectal cancer.
Lin W; Zhuang Q; Zheng L; Cao Z; Shen A; Li Q; Fu C; Feng J; Peng J
Oncol Rep; 2015 Apr; 33(4):1922-8. PubMed ID: 25653118
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells.
Kemper K; Prasetyanti PR; De Lau W; Rodermond H; Clevers H; Medema JP
Stem Cells; 2012 Nov; 30(11):2378-86. PubMed ID: 22969042
[TBL] [Abstract][Full Text] [Related]
29. Characterization of CD44-positive Cancer Stem-like Cells in COLO 201 Cells.
Okuyama H; Nogami W; Sato Y; Yoshida H; Tona Y; Tanaka Y
Anticancer Res; 2020 Jan; 40(1):169-176. PubMed ID: 31892565
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor (TGF) β1 acted through miR-130b to increase integrin α5 to promote migration of colorectal cancer cells.
Yi R; Li Y; Wang F; Gu J; Isaji T; Li J; Qi R; Zhu X; Zhao Y
Tumour Biol; 2016 Aug; 37(8):10763-73. PubMed ID: 26873488
[TBL] [Abstract][Full Text] [Related]
31. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
[TBL] [Abstract][Full Text] [Related]
32. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.
Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X
Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922
[TBL] [Abstract][Full Text] [Related]
33. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
[TBL] [Abstract][Full Text] [Related]
34. Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy.
Villalba M; Evans SR; Vidal-Vanaclocha F; Calvo A
Cell Tissue Res; 2017 Oct; 370(1):29-39. PubMed ID: 28560691
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
[TBL] [Abstract][Full Text] [Related]
36. Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer.
Yasunaga M; Matsumura Y
Sci Rep; 2014 Apr; 4():4852. PubMed ID: 24781822
[TBL] [Abstract][Full Text] [Related]
37. Musashi-1 promotes a cancer stem cell lineage and chemoresistance in colorectal cancer cells.
Chiou GY; Yang TW; Huang CC; Tang CY; Yen JY; Tsai MC; Chen HY; Fadhilah N; Lin CC; Jong YJ
Sci Rep; 2017 May; 7(1):2172. PubMed ID: 28526879
[TBL] [Abstract][Full Text] [Related]
38. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of HOXA4 and HOXA9 genes promotes self-renewal and contributes to colon cancer stem cell overpopulation.
Bhatlekar S; Viswanathan V; Fields JZ; Boman BM
J Cell Physiol; 2018 Feb; 233(2):727-735. PubMed ID: 28464221
[TBL] [Abstract][Full Text] [Related]
40. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M
Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
